GSA Capital Partners’s Biocept, Inc. BIOC Stock Holding History

GSA Capital Partners’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,088	Closed	-$371K	–	1924
2021 Q3	$371K	Sell	3,088 -1,963	-39%	-$229K	0.04%	883
2021 Q2	$635K	Buy	5,051 +3,749	+288%	+$507K	0.07%	479
2021 Q1	$199K	Buy	+1,302	New	+$236K	0.03%	915

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GSA Capital Partners's BIOC Position: Q4 2021 in Review

GSA Capital Partners sold out of Biocept, Inc. (BIOC) in Q4 2021, closing a stake of 3,088 shares — an estimated $371K sold.

GSA Capital Partners first reported a position in BIOC in Q1 2021 and held it in 3 quarters. The position peaked at $635K in Q2 2021. 33 funds tracked by Wall St. Rank hold BIOC as of Q4 2021.

GSA Capital Partners reported no remaining Biocept, Inc. position as of Q4 2021 after selling out during the quarter.
GSA Capital Partners sold 3,088 Biocept, Inc. shares in Q4 2021, an estimated $371K.
GSA Capital Partners first reported a position in Biocept, Inc. in Q1 2021 and held it in 3 quarters.
GSA Capital Partners's Biocept, Inc. position peaked at $635K in Q2 2021.
33 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2021.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.